Analysis of the efficacy of recombinant human growth hormone in the treatment of Turner syndrome
10.3760/cma.j.issn.1008-6706.2017.08.024
- VernacularTitle:重组人生长激素治疗特纳综合征的疗效分析
- Author:
Pingping ZHANG
;
Jie FANG
- Keywords:
Turner syndrome;
Recombinant human growth hormone;
Clinical effect
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(8):1217-1220
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical effect of recombinant human growth hormone(rhGH) in the treatment of Turner syndrome(TS).Methods The clinical data of 40 children with TS who were treated with rhGH were retrospectively analyzed.Results After treatment for 6 months,the GV,IGF-1 levels [(9.4 ± 2.7) cm/a,(433.9 ± 164.9)μg/L] were significantly higher than those before treatment [(2.5 ± 0.4)cm/a,(186.7 ± 7.33) μg/L],the differences were statistically significant(t =45.562 5,5.061 0,all P ＜ 0.05).The treatment dose of rhGH,initial treatment age had no significant relationship with GV,the GH peak before treatment had no significant correlation with GV.There was no obvious adverse reactions in the treatment process.Conclusion For children with TS,rhGH can improve the height,improve the therapeutic effect,reduce the burden of family and society.Low dose of rhGH in the treatment of TS can achieve better curative effect,the initial treatment age and growth rate in children had no obvious relationship,the insulin growth factor is an important index during the treatment,and the changes of insulin growth should be closely monitored,and adjusting the dosage of the drug in order to achieve the best therapeutic effect.
